These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5472573)

  • 1. [Correlation between disturbances of tryptophan metabolism induced by methionine and nialamide administration and changes of the mental state in chronic schizophrenic patients].
    Jus A; Rosengarten H; Wardaszko-Lyskowska H; Szemis A; Stencka K; Wlosińska I; Krzyzowski J; Kowalska K
    Psychiatr Pol; 1970; 4(4):365-71. PubMed ID: 5472573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disturbances of tryptophan metabolism during methionine and nialamide administration in chronic schizophrenic patients].
    Rosengarten H; Stencka K; Kowalska K; Wardaszko-Lyskowska H; Szemis A; Wlosińska I; Krzyzowski J; Jus A
    Psychiatr Pol; 1970; 4(3):261-8. PubMed ID: 5459695
    [No Abstract]   [Full Text] [Related]  

  • 3. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 5. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
    Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
    Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 7. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endogenous hallucinogens].
    Kanabus P; Frindt-Zajaczkowska A
    Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical research in schizophrenia.
    Boulton AA
    Nature; 1971 May; 231(5297):22-8. PubMed ID: 4930468
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and biochemical alterations in schizophrenic patients.
    Spaide J; Tanimukai H; Bueno JR; Himwich HE
    Arch Gen Psychiatry; 1968 Jun; 18(6):658-65. PubMed ID: 5651509
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
    Heller B
    Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
    [No Abstract]   [Full Text] [Related]  

  • 14. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.
    Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B
    Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood serum tryptophan in schizophrenic patients and the dependence of its level on treatment with neuroleptics].
    Szafranek J
    Ann Acad Med Stetin; 1970; 16():519-34. PubMed ID: 5525985
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tryptophan metabolism in schizophrenia].
    Rosengarten H; Marcjan K; Cwiertnia T; Stencka K; Rybus G
    Psychiatr Pol; 1970; 4(3):253-9. PubMed ID: 5459694
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.